We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current WVE market cap is 1.71B. The company's latest EPS is USD -0.4611 and P/E is -29.62.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 13.94M | 22.22M | 49.39M | 29.64M | 12.9M |
| Operating Income | -29.28M | -23.36M | 4.62M | -18.1M | -34.09M |
| Net Income | -27.41M | -21.1M | 7.25M | -16.26M | -31.56M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 15.98M | 20.08M | 40.96M | 3.66M | 115.18M |
| Operating Income | -198.58M | -151.32M | -122.48M | -162.71M | -66.12M |
| Net Income | -193.64M | -149.91M | -122.25M | -161.82M | -57.51M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 267.27M | 229.99M | 199.92M | 274.95M | 235.27M |
| Total Liabilities | 301.98M | 273.83M | 240.4M | 235.32M | 209.88M |
| Total Equity | -34.71M | -43.85M | -40.49M | 39.63M | 25.39M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 284.25M | 279.24M | 207.01M | 146.39M | 274.95M |
| Total Liabilities | 212.64M | 188.59M | 174.51M | 191.48M | 235.32M |
| Total Equity | 71.61M | 90.65M | 32.5M | -45.09M | 39.63M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 85.52M | 48.27M | 13.81M | -19.43M | -33.43M |
| Investing | -489k | -561k | -759k | -1.12M | -417k |
| Financing | 35.05M | 36.9M | 38.57M | 132.53M | 14.51M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -188.23M | -115.98M | -88.99M | -127.78M | -19.43M |
| Investing | -3.92M | -1.34M | -560k | -1.26M | -1.12M |
| Financing | 164.4M | 154.54M | 55.83M | 67.19M | 132.53M |
| Market Cap | 1.71B |
| Price to Earnings Ratio | -29.62 |
| Price to Sales Ratio | 14.79 |
| Price to Cash Ratio | 8.5 |
| Price to Book Ratio | 43 |
| Dividend Yield | - |
| Shares Outstanding | 124.74M |
| Average Volume (1 week) | 1.67M |
| Average Volume (1 Month) | 1.39M |
| 52 Week Change | 149.45% |
| 52 Week High | 16.735 |
| 52 Week Low | 3.50 |
| Spread (Intraday) | 0.17 (1.24%) |
| Company Name | Wave Life Sciences Ltd |
| Address |
8 cross street #10-00����� singapore 018936 |
| Website | https://www.wavelifesciences.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
